Table 1

Meta-analyses on the impact of MDT care on hospitalisation and mortality in HF

Meta-analysis	Number of studies	Number of patients	Outcome
Meta-analysis	Number of studies	Number of patients	All-cause mortality	All-cause hospitalisation	HF hospitalisation
McAlister et al 7*	29	5039	RR 0.75; 95% CI 0.59 to 0.96	RR 0.81; 95% CI 0.71 to 0.92	RR 0.74; 95% CI 0.63 to 0.87
Holland et al 8	30	8243	RR 0.79; 95% CI 0.69 to 0.92, P=0.002	RR 0.87; 95% CI 0.79 to 0.95, P=0.002	RR 0.70; 95% CI 0.61 to 0.8, P<0.001
Takeda et al 9	25	5942	OR 0.74; 95% CI 0.60 to 0.90, P=0.003		OR 0.57; 95% CI 0.43 to 0.75, P<0.001

*For interventions involving specialist MDT follow-up.
HF, heart failure; MDT, mltidisciplinary team; RR, relative risk.